BAX - Baxter International Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
15,113,000
15,113,000
12,784,000
11,673,000
11,362,000
Cost of revenue
9,716,000
9,716,000
7,679,000
7,086,000
6,601,000
Gross profit
5,397,000
5,397,000
5,105,000
4,587,000
4,761,000
Operating expenses
Research development
605,000
605,000
534,000
521,000
595,000
Selling general and administrative
3,862,000
3,887,000
2,867,000
2,469,000
3,290,000
Total operating expenses
4,467,000
4,528,000
3,395,000
2,971,000
3,885,000
Operating income or loss
930,000
869,000
1,710,000
1,616,000
876,000
Interest expense
415,000
395,000
192,000
134,000
111,000
Total other income/expenses net
-2,888,000
-2,827,000
-41,000
-190,000
165,000
Income before tax
-2,353,000
-2,353,000
1,477,000
1,292,000
970,000
Income tax expense
68,000
68,000
182,000
182,000
-41,000
Income from continuing operations
-2,421,000
-2,421,000
1,295,000
1,110,000
1,011,000
Net income
-2,433,000
-2,433,000
1,284,000
1,102,000
1,001,000
Net income available to common shareholders
-2,433,000
-2,433,000
1,284,000
1,102,000
1,001,000
Basic EPS
-
-4.83
2.56
2.17
1.97
Diluted EPS
-
-4.83
2.53
2.13
1.93
Basic average shares
-
504,000
502,000
509,000
509,000
Diluted average shares
-
504,000
508,000
517,000
519,000
EBITDA
-
-1,958,000
1,669,000
1,426,000
1,870,000